Peter Sorger, PhD

Otto Krayer Professor of Systems Pharmacology, Harvard Medical School
Fibroblast-tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways.
Authors: Authors: Zervantonakis IK, Poskus MD, Scott AL, Selfors LM, Lin JR, Dillon DA, Pathania S, Sorger PK, Mills GB, Brugge JS.
Proc Natl Acad Sci U S A
View full abstract on Pubmed
Inhibition of Haspin Kinase Promotes Cell-Intrinsic and Extrinsic Antitumor Activity.
Authors: Authors: Melms JC, Vallabhaneni S, Mills CE, Yapp C, Chen JY, Morelli E, Waszyk P, Kumar S, Deming D, Moret N, Rodriguez S, Subramanian K, Rogava M, Cartwright ANR, Luoma A, Mei S, Brinker TJ, Miller DM, Spektor A, Schadendorf D, Riggi N, Wucherpfennig KW, Sorger PK, Izar B.
Cancer Res
View full abstract on Pubmed
A multitargeted probe-based strategy to identify signaling vulnerabilities in cancers.
Authors: Authors: Rao S, Du G, Hafner M, Subramanian K, Sorger PK, Gray NS.
J Biol Chem
View full abstract on Pubmed
Common and cell-type specific responses to anti-cancer drugs revealed by high throughput transcript profiling.
Authors: Authors: Niepel M, Hafner M, Duan Q, Wang Z, Paull EO, Chung M, Lu X, Stuart JM, Golub TR, Subramanian A, Ma'ayan A, Sorger PK.
Nat Commun
View full abstract on Pubmed
Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs.
Authors: Authors: Hafner M, Niepel M, Chung M, Sorger PK.
Nat Methods
View full abstract on Pubmed
Metrics other than potency reveal systematic variation in responses to cancer drugs.
Authors: Authors: Fallahi-Sichani M, Honarnejad S, Heiser LM, Gray JW, Sorger PK.
Nat Chem Biol
View full abstract on Pubmed
Exploring the contextual sensitivity of factors that determine cell-to-cell variability in receptor-mediated apoptosis.
Authors: Authors: Gaudet S, Spencer SL, Chen WW, Sorger PK.
PLoS Comput Biol
View full abstract on Pubmed
Training signaling pathway maps to biochemical data with constrained fuzzy logic: quantitative analysis of liver cell responses to inflammatory stimuli.
Authors: Authors: Morris MK, Saez-Rodriguez J, Clarke DC, Sorger PK, Lauffenburger DA.
PLoS Comput Biol
View full abstract on Pubmed
Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity.
Authors: Authors: Cosgrove BD, King BM, Hasan MA, Alexopoulos LG, Farazi PA, Hendriks BS, Griffith LG, Sorger PK, Tidor B, Xu JJ, Lauffenburger DA.
Toxicol Appl Pharmacol
View full abstract on Pubmed
Physicochemical modelling of cell signalling pathways.
Authors: Authors: Aldridge BB, Burke JM, Lauffenburger DA, Sorger PK.
Nat Cell Biol
View full abstract on Pubmed